http://rdf.ncbi.nlm.nih.gov/pubchem/reference/1706648

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, N.I.H., Extramural|Research Support, N.I.H., Intramural
endingPage 3035
issn 0264-410X
issueIdentifier 24
pageRange 3026-3035
publicationName Vaccine
startingPage 3026
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_969ccf6fe026f2f48265f62ea5c814c6
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_7eb6d02dbbbe8c29dd4557038a063620
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_e0411b4181a684f4147fc136ddcb623e
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_3619a3c63379f8a1d8fe6ff1de219920
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_8be89a13f0cef6e0ef3efadeee10ce37
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_1af04d947be022776b62f04fea14f250
bibliographicCitation Jacobs A, Garg H, Viard M, Raviv Y, Puri A, Blumenthal R. HIV-1 envelope glycoprotein-mediated fusion and pathogenesis: implications for therapy and vaccine development. Vaccine. 2008 Jun 06;26(24):3026–35. PMID: 18242797; PMCID: PMC2490604.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4435a4b20326f1d8958f4d48cfccc959
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_30ea1d6b7467e43d39971703e1093536
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0f6f12641a10e4254b55edafc3727f2e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0c705082e677e56949dee4703285eb48
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3f9a7222d32254db059542e0a8dedb2e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_55e8b816125ddac57f99724a7d90a808
date 2008-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1016/j.vaccine.2007.12.026
https://pubmed.ncbi.nlm.nih.gov/18242797
https://pubmed.ncbi.nlm.nih.gov/PMC2490604
isPartOf https://portal.issn.org/resource/ISSN/0264-410X
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/7945
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title HIV-1 envelope glycoprotein-mediated fusion and pathogenesis: Implications for therapy and vaccine development
discusses http://id.nlm.nih.gov/mesh/M0519370
http://id.nlm.nih.gov/mesh/M0024085
http://id.nlm.nih.gov/mesh/M0002074
http://id.nlm.nih.gov/mesh/M0029275
http://id.nlm.nih.gov/mesh/M0365995
http://id.nlm.nih.gov/mesh/M0023609
http://id.nlm.nih.gov/mesh/M0025741
http://id.nlm.nih.gov/mesh/M0009501
http://id.nlm.nih.gov/mesh/M0064458
http://id.nlm.nih.gov/mesh/M0587317
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D016915Q000494
http://id.nlm.nih.gov/mesh/D015700Q000037
http://id.nlm.nih.gov/mesh/D053586Q000187
http://id.nlm.nih.gov/mesh/D015497Q000502
http://id.nlm.nih.gov/mesh/D008561Q000187
http://id.nlm.nih.gov/mesh/D015497Q000472
hasSubjectTerm http://id.nlm.nih.gov/mesh/D021962Q000502
http://id.nlm.nih.gov/mesh/D015700Q000502
http://id.nlm.nih.gov/mesh/D065100
http://id.nlm.nih.gov/mesh/D017209
http://id.nlm.nih.gov/mesh/D015335Q000378
http://id.nlm.nih.gov/mesh/D038301
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D023581Q000378
http://id.nlm.nih.gov/mesh/D001386Q000378
http://id.nlm.nih.gov/mesh/D002478
http://id.nlm.nih.gov/mesh/D019718Q000037
http://id.nlm.nih.gov/mesh/D015700Q000378
http://id.nlm.nih.gov/mesh/D006028Q000378
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8167
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_22520f951fef7fe92676186357deca6f
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_3b7b548dc433c7399ca3cf61af618a7a
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_68000b5f90a1d5b5b1a93dbb8aa92d3e
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5997

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID7852
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID920
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128121087
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1234
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID155971
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127929722

Total number of triples: 71.